The murder trial of Lindsay Clancy continued Tuesday in Plymouth, Massachusetts, with testimony from psychiatric nurse practitioner Rebecca Jollotta. Jollotta, who treated Clancy in late 2022, told the court that the defendant frequently requested changes to her prescribed medications. These requests persisted despite advice that the drugs required several weeks to provide therapeutic benefit.
During her time on the stand, Jollotta detailed the treatment plan she created to address Clancy’s reported anxiety, depression, and insomnia. According to Jollotta, Clancy voiced concerns about medication side effects, including intrusive thoughts and numbness, while also expressing anxiety regarding potential dependency on benzodiazepines. Jollotta testified that she believed these symptoms indicated postpartum depression rather than adverse reactions to the medication itself.
Clancy faces three counts of murder for the 2023 deaths of her children, Cora, Dawson, and Callan. While prosecutors assert that the defendant acted intentionally and sought simple fixes for her mental health struggles, the defense maintains that she suffered from a psychotic episode linked to postpartum illness. Defense attorneys have challenged the level of care Clancy received from her medical providers, arguing that the treatment process was flawed.
Jollotta is one of several medical professionals called to testify during the ongoing trial, which is currently in its third week. She noted that during their final contact in December 2022, Clancy appeared to understand her treatment plan and was able to advocate for her own needs. Jollotta stated that at no point did the patient indicate a plan to harm herself or her children.
The trial proceedings have featured testimony regarding the numerous medications Clancy took in the months leading up to the tragedy. As the legal process continues, the court is expected to hear from further witnesses over the next several weeks. Clancy remains in state custody at Tewksbury Hospital.